Logo
Logo

About Lacidipine API

Product
  • Therapeutic CategoryCardiovascular

  • CAS Number

    103890-78-4

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    EUDMF

Mechanism of Action

Calcium channel blocker

Indication

Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors

Related APIs

Amlodipine Besylate

Cardiovascular

arrow

Apixaban

Cardiovascular

arrow

Atorvastatin Calcium (Amorphous And Form 1)

Cardiovascular

arrow

Bempedoic Acid

Cardiovascular

arrow

Clopidogrel Bisulfate (Form 1)

Cardiovascular

arrow

Clopidogrel Bisulfate (Form 2)

Cardiovascular

arrow

Dabigatran Etexilate Mesylate

Cardiovascular

arrow

Doxazosin Mesylate

Cardiovascular

arrow

Ezetimibe

Cardiovascular

arrow

Fondaparinux Sodium

Cardiovascular

arrow

Lacidipine

Cardiovascular

arrow

Losartan Potassium

Cardiovascular

arrow

Mavacamten

Cardiovascular

arrow

Metoprolol Succinate

Cardiovascular

arrow

Ramipril

Cardiovascular

arrow

Rivaroxaban

Cardiovascular

arrow

Sacubitril / Valsartan

Cardiovascular

arrow

Tafamidis Free Acid

Cardiovascular

arrow

Tafamidis Meglumine

Cardiovascular

arrow

Ticagrelor

Cardiovascular

arrow

Treprostinil

Cardiovascular

arrow

Treprostinil Olamine

Cardiovascular

arrow

Valsartan

Cardiovascular

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.